论文部分内容阅读
肿瘤免疫基因治疗为肿瘤治疗提供了新的途径,趋化因子和共刺激分子B7在肿瘤免疫基因治疗研究中发挥着重要的作用。B7通过为T细胞激活提供第二信号,趋化因子MIP-lα能趋化T细胞、单核细胞、树突状细胞、NK细胞等在抗肿瘤免疫中有相应作用的细胞,从而产生抗肿瘤效应。研究表明[1]
Tumor immune gene therapy provides a new way for tumor therapy. Chemokine and costimulatory molecule B7 play an important role in tumor immunotherapy. B7, by providing a second signal for T cell activation, chemotactic factor MIP-1α can chemotactic to T cells, monocytes, dendritic cells, NK cells and other cells that have a corresponding role in antitumor immunity to produce anti-tumor effect. Research shows that [1]